CNC vs PROF · P/E 8.4, rev $163.07B vs rev $10.7M
Centene Corp (CNC) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. PROF currently screens at market cap $238.7M.
Not investment advice. Open the CNC and PROF stock pages for the full models.
Not investment advice.